J Korean Diabetes.  2022 Dec;23(4):278-281. 10.4093/jkd.2022.23.4.278.

A Case of Fulminant Type 1 Diabetes Mellitus after Recovery from COVID-19 Infection

• Suh DW
• Lee CG
• Lee HK
• Kim JT

• KMID: 2538099
• DOI: http://doi.org/10.4093/jkd.2022.23.4.278

Abstract

testing revealed that the patient was positive for HLA-DRB1*04, HLA-DRB1*12, HLA-DQB1*03, and HLA-DQB1*04. To the best of our knowledge, this is the first case of fulminant T1DM reported to occur immediately after COVID-19 infection.

Keyword

Type 1 diabetes; COVID-19

Reference

1.Wang Z., Zheng Y., Tu Y., Dai Z., Lin J., Zhou Z. Immuno-logical aspects of fulminant type 1 diabetes in Chinese. J Immunol Res. 2016. 2016:1858202.

2.Chujo D., Kawabe A., Matsushita M., Takahashi N., Tsut-sumi C., Haseda F, et al. Distinct phenotypes of islet anti-gen-specific CD⁴⁺ T cells among the 3 subtypes of type 1 diabetes. J Clin Endocrinol Metab. 2020. 105:dgaa447.

3.Kwak SH., Kim YJ., Chae J., Lee CH., Han B., Kim JI, et al. Association of HLA genotype and fulminant type 1 diabetes in Koreans. Genomics Inform. 2015. 13:126–31.

4.Müller JA., Groß R., Conzelmann C., Krüger J., Merle U., Steinhart J, et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021. 3:149–65.

5.Wu CT., Lidsky PV., Xiao Y., Lee IT., Cheng R., Nakayama T, et al. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Cell Metab. 2021. 33:1565–76.e5.

6.Unsworth R., Wallace S., Oliver NS., Yeung S., Kshirsagar A., Naidu H, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care. 2020. 43:e170–1.

7.Vlad A., Serban V., Timar R., Sima A., Botea V., Albai O, et al. Increased incidence of type 1 diabetes during the COVID-19 pandemic in Romanian children. Medicina (Kaunas). 2021. 57:973.

8.Tang X., He B., Liu Z., Zhou Z., Li X. Fulminant type 1 diabetes after COVID-19 vaccination. Diabetes Metab. 2022. 48:101324.